Pick A W, Orszulak T A, Anderson B J, Schaff H V
Section of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota 55905, USA.
Ann Thorac Surg. 1997 Sep;64(3):599-605. doi: 10.1016/s0003-4975(97)00620-6.
The superior long-term patency of the internal mammary artery (IMA) confers important short-term and late survival advantages when grafted to the left anterior descending coronary artery. However, it remains uncertain whether patients derive additional survival benefit when both IMAs are used in coronary revascularization.
Between June 1983 and May 1986, 160 patients (mean age 60 years) received bilateral IMA grafts for coronary artery bypass procedures, and in 93% of patients, the right IMA was used to bypass the left coronary system. During a similar interval, a group of 161 patients matched for symptomatic status and extent of disease (mean age, 62 years) received a single left IMA and saphenous vein grafts.
The two groups were similar with respect to gender, preoperative angina class, priority status, extent of coronary artery disease, left ventricular function, and number of distal anastomoses. Diabetes was more prevalent in the patient group receiving a single IMA graft (27% versus 17.5%; p = 0.05). Early outcome was similar in the two groups; operative mortality was 0.6% for the patient group receiving single IMA grafts and 0% for those with bilateral IMA grafts. The mean follow-up of 320 hospital survivors was 10 years. Univariate analysis revealed significantly fewer overall deaths in the patients receiving bilateral IMA grafts (n = 30; p = 0.05), and less late cardiac mortality (n = 12; p = 0.016). Ten-year actuarial survival for patients dismissed from the hospital was 76% for those receiving single IMA graft versus 85% for those receiving bilateral IMA grafts. Multivariate analysis revealed diabetes (risk ratio = 1.73), advancing age (risk ratio = 1.08), and lower ejection fraction (risk ratio = 1.01) to be the only significant predictors of late cardiac death. Use of a single IMA graft was not significant (p = 0.138) despite a risk ratio of 1.78. Use of only a single IMA graft correlated with an increased risk of angina recurrence (p < 0.001), late myocardial infarction (p = 0.019), and risk of any cardiac event (p < 0.001).
Independent risk factors for late death were diabetes mellitus, older age, and reduced ejection fraction. Patients receiving bilateral IMA grafts had better long-term survival than those with a single IMA graft, but this was not independent of diabetes. Multivariate analysis, however, did confirm that compared with single arterial grafts, bilateral IMA grafting was an independent predictor of lower rates of angina recurrence, late myocardial infarction, and the composite end point of any cardiac event.
乳内动脉(IMA)长期通畅性良好,当移植至左前降支冠状动脉时,具有重要的短期和远期生存优势。然而,在冠状动脉血运重建中使用双侧IMA时,患者是否能获得额外的生存益处仍不确定。
1983年6月至1986年5月期间,160例患者(平均年龄60岁)接受双侧IMA移植进行冠状动脉搭桥手术,93%的患者使用右侧IMA绕过左冠状动脉系统。在相似时间段内,一组161例症状状态和疾病范围相匹配的患者(平均年龄62岁)接受了单根左IMA和大隐静脉移植。
两组在性别、术前心绞痛分级、优先状态、冠状动脉疾病范围、左心室功能和远端吻合口数量方面相似。接受单根IMA移植的患者组中糖尿病更为普遍(27%对17.5%;p = 0.05)。两组的早期结果相似;接受单根IMA移植的患者组手术死亡率为0.6%,接受双侧IMA移植的患者组为0%。320例住院幸存者的平均随访时间为10年。单因素分析显示,接受双侧IMA移植的患者总体死亡人数显著较少(n = 30;p = 0.05),晚期心脏死亡人数也较少(n = 12;p = 0.016)。出院患者的10年精算生存率,接受单根IMA移植的患者为76%,接受双侧IMA移植的患者为85%。多因素分析显示,糖尿病(风险比 = 1.73)、年龄增长(风险比 = 1.08)和较低的射血分数(风险比 = 1.01)是晚期心脏死亡的唯一显著预测因素。尽管风险比为1.78,但使用单根IMA移植并不显著(p = 0.138)。仅使用单根IMA移植与心绞痛复发风险增加(p < 0.001)、晚期心肌梗死风险增加(p = 0.019)以及任何心脏事件风险增加(p < 0.001)相关。
晚期死亡的独立危险因素为糖尿病、老年和射血分数降低。接受双侧IMA移植的患者比接受单根IMA移植的患者具有更好的长期生存率,但这并非独立于糖尿病因素。然而,多因素分析确实证实,与单根动脉移植相比,双侧IMA移植是心绞痛复发率、晚期心肌梗死以及任何心脏事件复合终点发生率较低的独立预测因素。